Neuphoria Therapeutics Inc (NEUP) — Cash Flow Reinvestment Rate
Neuphoria Therapeutics Inc (NEUP) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting $3.00 (capex $3.00 ) from operating cash flow of $73.57 Million. See free cash flow generation of Neuphoria Therapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Neuphoria Therapeutics Inc Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for Neuphoria Therapeutics Inc across 2 annual periods. For the full cash flow conversion analysis, see NEUP cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Neuphoria Therapeutics Inc (2015–2025)
Year-by-year capital reinvestment analysis for Neuphoria Therapeutics Inc. See NEUP free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | $0.00 | $77.23 Million | $0.00 | ▼ -100.0% |
| 2015 | 0.17x | $846.26K | $4.94 Million | $846.26K | — |